These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 37047285)

  • 21. Parkinson's disease--a multifactorial neurodegenerative disorder.
    Riess O; Krüger R
    J Neural Transm Suppl; 1999; 56():113-25. PubMed ID: 10370906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Senescence and impaired DNA damage responses in alpha-synucleinopathy models.
    Yoon YS; You JS; Kim TK; Ahn WJ; Kim MJ; Son KH; Ricarte D; Ortiz D; Lee SJ; Lee HJ
    Exp Mol Med; 2022 Feb; 54(2):115-128. PubMed ID: 35136202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of thioredoxin reductase 1 can reduce DNA damage, mitochondrial autophagy and endoplasmic reticulum stress in Parkinson's disease.
    Liu Z; Ye Q; Wang F; Guo Y; Cui R; Wang J; Wang D
    Exp Brain Res; 2021 Feb; 239(2):475-490. PubMed ID: 33230666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant Role of Long Non-coding RNAs in Parkinson's Disease.
    Na C; Wen-Wen C; Li W; Ao-Jia Z; Ting W
    Curr Pharm Des; 2022; 28(37):3085-3094. PubMed ID: 36154598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases.
    Izco M; Carlos E; Alvarez-Erviti L
    Neurobiol Dis; 2022 May; 166():105651. PubMed ID: 35124191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease.
    Wang HQ; Takahashi R
    Antioxid Redox Signal; 2007 May; 9(5):553-61. PubMed ID: 17465880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurodegenerative Disorders and the Current State, Pathophysiology, and Management of Parkinson's Disease.
    Rahul ; Siddique Y
    CNS Neurol Disord Drug Targets; 2022; 21(7):574-595. PubMed ID: 34477534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of α-Synuclein Oligomers in Parkinson's Disease.
    Du XY; Xie XX; Liu RT
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's Disease: A Current Perspectives on Parkinson's Disease and Key Bioactive Natural Compounds as Future Potential Drug Candidates.
    Ali N; Syeda A; Topgyal T; Gaur N; Islam A
    Curr Drug Targets; 2022; 23(1):2-20. PubMed ID: 34165406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
    Lim KL
    Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
    Singh N; Haldar S; Tripathi AK; McElwee MK; Horback K; Beserra A
    Antioxid Redox Signal; 2014 Jul; 21(3):471-84. PubMed ID: 24512387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses.
    Trojanowski JQ; Lee VM
    Neurotoxicology; 2002 Oct; 23(4-5):457-60. PubMed ID: 12428717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease.
    Drechsel DA; Patel M
    Free Radic Biol Med; 2008 Jun; 44(11):1873-86. PubMed ID: 18342017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease and the gut: Models of an emerging relationship.
    Bindas AJ; Kulkarni S; Koppes RA; Koppes AN
    Acta Biomater; 2021 Sep; 132():325-344. PubMed ID: 33857691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more….
    Rouaud T; Corbillé AG; Leclair-Visonneau L; de Guilhem de Lataillade A; Lionnet A; Preterre C; Damier P; Derkinderen P
    Rev Neurol (Paris); 2021 Mar; 177(3):260-271. PubMed ID: 33032797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbes and Parkinson's disease: from associations to mechanisms.
    Cannon T; Gruenheid S
    Trends Microbiol; 2022 Aug; 30(8):749-760. PubMed ID: 35144890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.